Clinical Trial

Effects of Whole-body Electrostimulation on Patients With Chronic Kidney Disease

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 18, 2024 (before its estimated December 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
Chronic kidney disease (CKD) consists of kidney damage, with consequent progressive and irreversible loss of kidney function. In the early stages of the disease, a reduction in circulating levels of the α-klotho protein is already observed, which is related to worsening renal function. Therapeutic strategies that increase serum levels of α-klotho may be of great value in the treatment of CKD. Electrical stimulation contributes to the reduction of reactive oxygen species, DNA damage and improves the effectiveness rate of dialysis, suggesting a systemic effect in patients with terminal CKD. The objective of this study is to evaluate the effects of whole body electrical stimulation on renal function and physical capacity in patients with CKD not dependent on dialysis.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06502522
Lead Sponsor Federal University of Health Science of Porto Alegre
Collaborators: Leonhardt Ventures LLC
Conditions Renal Insufficiency, Chronic
Enrollment 30 participants
Start Date 2024-08-01
Primary Completion 2024-12-01 (estimated)
Study Completion 2025-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-18